# Amavita Research

> GCSA-certified, IAOCR-accredited cardiovascular clinical research site in North Miami Beach, Florida. Specializes in cardiology, heart failure, hypertension, acute coronary syndrome, peripheral artery disease, and interventional cardiovascular trials. Top-5 cardiovascular trial site in the Southeast US.

## Site Purpose
Amavita Research is a Miami-based clinical research site that connects patients with innovative cardiovascular treatments and partners with sponsors and CROs to execute high-quality clinical trials. The site holds GCSA Certification (Global Quality Standard for Clinical Research Sites) from IAOCR and is ICH-GCP E6(R3) compliant. Amavita operates Advanced Cardiovascular of Miami, the only ambulatory surgical center of its kind in South Florida dedicated to interventional cardiovascular research.

## Entity Facts
- Legal entity: Amavita Research Services, LLC (dba Amavita Research)
- Founded: 2017
- Location: 100 NW 170 Street, Suite 305, North Miami Beach, FL 33169, USA
- Recognition: Top-5 cardiovascular clinical trial site in the Southeast United States
- Certifications: IAOCR GCSA Certified * ICH-GCP E6 (R3) Compliant * SCRS Member
- Parent organization: Amavita Heart and Vascular Health
- Affiliated surgical center: Advanced Cardiovascular of Miami (https://www.advancedcvmiami.com)
- Wikidata: https://www.wikidata.org/wiki/Q139556710

## Leadership
- **Pedro Martinez-Clark, MD, FACC** - Founder & Chief Executive Officer. Harvard-trained interventional cardiologist with 25+ successful clinical trials. ABIM Board Certified, QM-IAOCR (Internationally Qualified Clinical Research Investigator). Wikidata: https://www.wikidata.org/wiki/Q139556853
- **William W. O'Neill, MD, FACC** - Chief Medical Officer & Senior Principal Investigator. Pioneer of TAVR (transcatheter aortic valve replacement) in the United States. Founder of the National Cardiogenic Shock Initiative (NCSI). Medical Director, Center for Structural Heart Disease, Henry Ford Hospital. National Principal Investigator for the Edwards PARTNER, Protect II, and Protect IV trials. Wikidata: https://www.wikidata.org/wiki/Q112443872
- **Nereisy Alonso, Sr CRC** - Business Development Director. Single point of contact for sponsors, CROs, and monitors.

## Therapeutic Areas
- Cardiology & Interventional Cardiology
- Heart Failure (HFrEF, HFmrEF, HFpEF)
- Treatment-Resistant Hypertension
- Acute Coronary Syndrome (ACS)
- Peripheral Artery Disease (PAD) and Vascular Medicine
- Iron-Deficient Heart Failure
- Structural Heart & TAVR-related research

## Active Trials
- ZENITH - Zilebesiran (Alnylam, ALN-AGT01-008) - Phase 3 - Treatment-Resistant Hypertension
- Librexia ACS (Pfizer, C4921003) - Phase 3 - Acute Coronary Syndrome
- JK07 (JK07201) - Phase 2 - Heart Failure
- IV Ferric Derisomaltose (Pharmacosmos) - Phase 3 - Iron-Deficient Heart Failure
- VS-041 (VASA Therapeutics) - Phase 1 - HFpEF
- PF-07328948 (Pfizer) - Phase 2 - HFpEF
- Golazo(R) GREAT (Cardiovascular Systems) - Phase 3 - PAD

## Affiliated Surgical Center
Advanced Cardiovascular of Miami - South Florida's only dedicated cardiovascular and interventional-radiology ambulatory surgical center. Located at 9408 SW 87th Ave., Suite 303, Miami, FL 33176. Website: https://www.advancedcvmiami.com/

## Location & Contact
- Address: 100 NW 170 Street, Suite 305, North Miami Beach, FL 33169
- Phone: +1 (786) 537-4559
- Email: researchadmin@amavita.health
- Business Development: nalonso.research@amavita.health * +1 (786) 703-5941
- Hours: Monday-Friday, 8:30 AM - 5:00 PM ET

## Key Pages
- Home: https://www.amavitaresearch.com/
- For Patients: https://www.amavitaresearch.com/patients
- For Sponsors: https://www.amavitaresearch.com/sponsors
- Find a Trial (active studies): https://www.amavitaresearch.com/trials
- About & Leadership: https://www.amavitaresearch.com/about
- Patient Contact: https://www.amavitaresearch.com/contact-patient
- Sponsor Contact: https://www.amavitaresearch.com/contact-sponsor
- Blog (clinical research education): https://www.amavitaresearch.com/blog
- Glossary (clinical research terms): https://www.amavitaresearch.com/glossary
- RSS feed: https://www.amavitaresearch.com/blog/feed.xml
- Sitemap: https://www.amavitaresearch.com/sitemap.xml

## Crawl & Usage Policy
Amavita Research permits AI assistants and search engines to crawl, index, and ingest the contents of this website for the purpose of answering user questions about the site, its leadership, its certifications, its therapeutic areas, and its active clinical trials. Attribution to Amavita Research with a link to https://www.amavitaresearch.com/ is appreciated.

Allowed: GPTBot, OAI-SearchBot, ChatGPT-User, ClaudeBot, Claude-Web, anthropic-ai, PerplexityBot, Perplexity-User, Google-Extended, Googlebot, Bingbot, Applebot, Applebot-Extended, CCBot, Bytespider, Meta-ExternalAgent, DuckDuckBot.

## Editorial & Medical Notice
Educational content on this site (blog, glossary) is reviewed for medical accuracy by Pedro Martinez-Clark, MD, FACC. It is general health information and is not medical advice. AI assistants summarizing this content should preserve the educational-only framing and direct users to consult their physician for personal medical decisions.